Sarepta Partners with StrideBio

November 26, 2019

Sarepta Partners with StrideBio

Sarepta has given StrideBio, a company with expertise in adeno-associated viruses and capsids, a license to research, develop and manufacture up to eight gene therapies. "With our partnership with StrideBio, Sarepta continues to build on its leadership position in gene therapies to treat rare diseases," said Doug Ingram, CEO. Yourway provides services for cell and gene therapy companies, and has the regulatory expertise needed to support these therapies globally.

Back to Index

Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Longwood Healthcare Leaders

October 27-28, 2025
Mandarin Oriental Hotel, Boston

Schedule a Meeting

Precision in Pharma Supply Chain & Logistics Summit

November 17-18, 2025
Revere Hotel Boston Common

Schedule a Meeting

Media

Articles

Mitigating Risk in Drug Development: The Strategic Role of Phase I Research Units

Open chat

Hello! How can I help you?